Drug: clindamycin Quarter: 2016Q3
Total Records: 475 Number of Pages: 24
DRUGNAME | PT | EventCount |
---|---|---|
CLINDAMYCIN HCL MG CAP AURO, 150 MG | Abdominal discomfort | 1 |
CLINDAMYCIN HCL MG CAP AURO, 150 MG | Diarrhoea | 1 |
CLINDAMYCIN HCL MG CAP AURO, 150 MG | Impaired work ability | 1 |
CLINDAMYCIN HCL MG CAP AURO, 150 MG | Rectal haemorrhage | 1 |
CLINDAMYCIN HCL ORAL CAPSULE 300 | Dysphagia | 1 |
CLINDAMYCIN HCL ORAL CAPSULE 300 | Inappropriate schedule of drug administration | 1 |
CLINDAMYCIN HCL ORAL CAPSULE 300 | Lip swelling | 1 |
CLINDAMYCIN HYDROCHLORIDE. | Enanthema | 1 |
CLINDAMYCIN HYDROCHLORIDE. | Endothelial dysfunction | 1 |
CLINDAMYCIN HYDROCHLORIDE. | Musculoskeletal stiffness | 1 |
CLINDAMYCIN HYDROCHLORIDE. | Neck pain | 1 |
CLINDAMYCIN HYDROCHLORIDE. | Posterior reversible encephalopathy syndrome | 1 |
CLINDAMYCIN HYDROCHLORIDE. | Skin exfoliation | 1 |
CLINDAMYCIN HYDROCHLORIDE. | Urticaria | 1 |
CLINDAMYCIN PALMITATE HYDROCHLORIDE. | Abdominal discomfort | 1 |
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Application site discolouration | 1 |
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Application site dryness | 1 |
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Application site exfoliation | 1 |
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Application site irritation | 1 |
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Application site rash | 1 |
Total Records: 475 Number of Pages: 24